The Recall Desk
ModerateFDA (Drugs)·D-0200-2026·Announced 2025-12-10

Compounded phenylephrine syringes recalled over current good manufacturing practice deviations

Park Avenue Compounding is recalling 858 syringes of Phenylephrine HCl, 1000 mcg / 10 mL, over current good manufacturing practice deviations.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: Scored 2 because the record cites current good manufacturing practice deviations with no stated product defect or reported harm.

Plain-English summary

Phenylephrine HCl, 1000 mcg / 10 mL, in a 10 mL total volume syringe, prescription only, from Park Avenue Compounding of Saint Louis, Missouri, under NDC 83863-0104-1, is being recalled.

The reason given in the enforcement record is CGMP deviations.

The recall covers 858 syringes from lot 20250813-13D65E, expiry FEB-09-2026. Distribution was in Missouri. The FDA has classified the action as Class II.

The record cites manufacturing practice deviations without describing a specific product defect, and states no injuries. Facilities should follow the firm's instructions.

The recalled product

Product
Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.
Manufacturer
Park Avenue Compounding
Hazard
  • cgmp-deviation
  • compounding
  • manufacturing-quality

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 20250813-13D65E
  • Exp Date: FEB-09-2026.

Distribution

Distributed in 1 state:

  • MO